Medicare Enrolled

Dr. Kathleen Cooper, FNP-C

Nurse Practitioner - Family · Albany, GA
Low-engagement
417 W 3RD AVE, Albany, GA 31701
2293122380
In practice since 2015 (11 years)
NPI: 1659754521 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cooper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cooper? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cooper

Dr. Kathleen Cooper is a nurse practitioner - family in Albany, GA, with 11 years of NPI registration.

Between the years covered by Open Payments, Dr. Cooper received a total of $7,379 from 27 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cooper is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice $7,379 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$7,379
Total received (2021-2024)
Avg $1,845/year across 4 years
Top 2% in GA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
250
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,123 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$256 (3.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,832
2023
$2,301
2022
$1,330
2021
$916

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$2,188
Sumitomo Pharma America, Inc.
$182
Astellas Pharma US Inc
$145
Teleflex LLC
$59
Axonics, Inc.
$59
Janssen Biotech, Inc.
$53
ABBVIE INC.
$39
Myriad Genetic Laboratories, Inc.
$21
Antares Pharma, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Bayer Healthcare Pharmaceuticals Inc.
$16
Lilly USA, LLC
$16
Tolmar, Inc.
$15
Top 3 companies account for 88.8% of 2024 payments
All-time payments by company (2021-2024) ›
Medtronic, Inc.
$3,582
Astellas Pharma US Inc
$745
Sumitomo Pharma America, Inc.
$598
Myovant Sciences Inc.
$280
UROVANT SCIENCES INC
$268
Dendreon Pharmaceuticals LLC
$266
Antares Pharma, Inc.
$239
Merck Sharp & Dohme LLC
$226
Janssen Biotech, Inc.
$204
AstraZeneca Pharmaceuticals LP
$193
ABBVIE INC.
$110
Supernus Pharmaceuticals, Inc.
$101
Endo Pharmaceuticals Inc.
$89
Teleflex LLC
$59
Axonics, Inc.
$59
Boston Scientific Corporation
$54
180 Medical, Inc.
$52
Bayer Healthcare Pharmaceuticals Inc.
$47
Bayer HealthCare Pharmaceuticals Inc.
$47
Tolmar, Inc.
$35
AbbVie Inc.
$27
Myriad Genetic Laboratories, Inc.
$21
Amgen Inc.
$18
Lilly USA, LLC
$16
BOSTON SCIENTIFIC CORPORATION
$15
Sun Pharmaceutical Industries Inc.
$14
Acerus Pharmaceuticals Corporation
$14
Top 3 companies account for 66.7% of all-time payments
Associated products mentioned in payments ›
AVEED · Axonics · BOTOX · ELIGARD · ERLEADA · GEMTESA · GENTLECATH GLIDE · INTERSTIM · KEYTRUDA · LUPRON DEPOT · LYNPARZA · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · Rezum Generator · SPACEOAR VUE · SPEEDICATH · TLANDO · UROLIFT · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for nurse practitioner - family in GA.

Looking for a nurse practitioner - family in Albany?
Compare family nurse practitioners in the Albany area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
169
Per 100K population
201.4
County median income
$46,784
Nearest hospital
PHOEBE WORTH MEDICAL CENTER
15.6 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cooper is a nurse practitioner - family, with low-engagement industry engagement in the top 2% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Cooper receive payments from pharmaceutical companies?
Yes. Dr. Cooper received a total of $7,379 from 27 companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Cooper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Albany
Browse family nurse practitioners in Albany ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in GA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in GA
Which GA family nurse practitioners receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →